share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Mar 25 09:05

Gainers

  • Landos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press release, Q4 earnings came out 2 days ago.
  • Altamira Therapeutics (NASDAQ:CYTO) shares rose 49.71% to $2.59. The market value of their outstanding shares is at $4.7 million.
  • Esperion Therapeutics (NASDAQ:ESPR) stock increased by 21.83% to $2.79. The company's market cap stands at $516.2 million.
  • Salarius Pharmaceuticals (NASDAQ:SLRX) shares moved upwards by 21.66% to $0.75. The company's market cap stands at $2.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Neuronetics (NASDAQ:STIM) stock increased by 18.19% to $5.0. The market value of their outstanding shares is at $148.7 million.
  • Nkarta (NASDAQ:NKTX) stock rose 17.93% to $10.52. The market value of their outstanding shares is at $516.2 million. As per the news, the Q4 earnings report came out 2 days ago.

Losers

  • SINTX Techs (NASDAQ:SINT) stock declined by 46.5% to $0.05 during Monday's pre-market session.
  • Akanda (NASDAQ:AKAN) stock declined by 32.2% to $0.17. The market value of their outstanding shares is at $1.4 million.
  • Trxade Health (NASDAQ:MEDS) stock declined by 30.42% to $16.75. The market value of their outstanding shares is at $20.1 million.
  • Nuvation Bio (NYSE:NUVB) shares declined by 18.62% to $1.88. The company's market cap stands at $411.8 million.
  • Yield10 Bioscience (NASDAQ:YTEN) stock fell 11.82% to $0.33. The market value of their outstanding shares is at $3.9 million.
  • Virios Therapeutics (NASDAQ:VIRI) stock declined by 9.27% to $0.41. The market value of their outstanding shares is at $7.9 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment